Medicinal plants consumption against urinary tract infections: a narrative review of the current evidence

References

• El-Sayed SM, Youssef AM. Potential application of herbs and spices and their effects in functional dairy products. Heliyon. 2019;5(6):e01989.
   PubMed Web of Science ®Google Scholar
• Leja KB, Czaczyk K. The industrial potential of herbs and spices - a mini review. Acta Sci Pol Technol Aliment. 2016;15(4):353–365.
   PubMed Web of Science ®Google Scholar
• Nagai T, Inoue R. Preparation and functional properties of water extract and alkaline extract of royal jelly. Food Chem. 2004;84(2):181–186.
   Web of Science ®Google Scholar
• Viuda-Martos M, Ruiz-Navajas Y, Fernández-López J, et al. Spices as functional foods. Crit Rev Food Sci Nutr. 2011;51(1):13–28.
   PubMed Web of Science ®Google Scholar
• Nørgaard SM, Jensen CS, Aalestrup J, et al. Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review. Antimicrob Resist Infect Control. 2019;8:170.
   PubMed Web of Science ®Google Scholar
• Ayaz M, Subhan F, Ahmed J, et al. Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance. J Biol Res (Thessalon). 2015;22(1):4.
   PubMedGoogle Scholar
• Sanhueza L, Melo R, Montero R, et al. Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli. PLoS One. 2017;12(2):e0172273.
   PubMed Web of Science ®Google Scholar
• Cheesman MJ, Ilanko A, Blonk B, et al. Developing new antimicrobial therapies: are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution? Pharmacogn Rev. 2017;11(22):57–72.
   PubMedGoogle Scholar
• Betoni JE, Mantovani RP, Barbosa LN, et al. Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem Inst Oswaldo Cruz. 2006;101(4):387–390.
   PubMed Web of Science ®Google Scholar
• Hemaiswarya S, Kruthiventi AK, Doble M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine. 2008;15(8):639–652.
   PubMed Web of Science ®Google Scholar
• Ayaz M, Ullah F, Sadiq A, et al. Synergistic interactions of phytochemicals with antimicrobial agents: potential strategy to counteract drug resistance. Chem Biol Interact. 2019;308:294–303.
   PubMed Web of Science ®Google Scholar
• Wińska K, Mączka W, Łyczko J, et al. Essential oils as antimicrobial agents-myth or real alternative? Molecules. 2019;24(11):2130.
   PubMed Web of Science ®Google Scholar
• Kalemba D, Kunicka A. Antibacterial and antifungal properties of essential oils. Curr Med Chem. 2003;10(10):813–829.
   PubMed Web of Science ®Google Scholar
• Furneri PM, Fuochi V, Lissandrello E, et al. The antimicrobial activity of essential oils against multi-drug-resistance microorganisms: a review. Front Anti-Infective Drug Discovery. 2017;5:23–54.
   Google Scholar
• Reavill DR, Lennox AM. Disease Overview of the Urinary Tract in Exotic Companion Mammals and Tips on Clinical Management. Vet Clin North Am Exot Anim Pract. 2020;23(1):169–193.
   PubMedGoogle Scholar
• Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1–13.
   PubMed Web of Science ®Google Scholar
• Hannan TJ, Totsika M, Mansfield KJ, et al. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev. 2012;36(3):616–648.
   PubMed Web of Science ®Google Scholar
• Nielubowicz GR, Mobley HL. Host–pathogen interactions in urinary tract infection. Nature Rev Urol. 2010;7(8):430–441.
   PubMed Web of Science ®Google Scholar
• Flores-Mireles AL, Walker JN, Caparon M, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284.
   PubMed Web of Science ®Google Scholar
• Shah C, Baral R, Bartaula B, et al. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol. 2019;19(1):204.
   PubMed Web of Science ®Google Scholar
• Becknell B, Schober M, Korbel L, et al. The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev Anti Infect Ther. 2015;13(1):81–90.
   PubMed Web of Science ®Google Scholar
• Quigley R. Diagnosis of urinary tract infections in children. Curr Opin Pediatr. 2009;21(2):194–198.
   PubMed Web of Science ®Google Scholar
• Byington CL, Rittichier KK, Bassett KE, et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics. 2003;111(5):964–968.
   PubMed Web of Science ®Google Scholar
• Bachur R, Harper MB. Reliability of the urinalysis for predicting urinary tract infections in young febrile children. Arch Pediatr Adolesc Med. 2001;155(1):60–65.
   PubMedGoogle Scholar
• Hellerstein S, Linebarger JS. Voiding dysfunction in pediatric patients. Clin Pediatrics. 2003;42:43–49.
   PubMed Web of Science ®Google Scholar
• Korbel L, Howell M, Spencer JD. The clinical diagnosis and management of urinary tract infections in children and adolescents. Paediatr Int Child Health. 2017;37(4):273–279.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Women’s and Children’s Health. Urinary tract infection in children: diagnosis, treatment and long-term management. London (UK): RCOG Press; 2007.
   Google Scholar
• Smellie JM, Grüneberg RN, Leakey A, et al. Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: clinical aspects. Br Med J. 1976;2:203–206.
   PubMed Web of Science ®Google Scholar
• Normand IC, Smellie JM. Prolonged maintenance chemotherapy in the management of urinary infection in childhood. Br Med J. 1965;1:1023–1026.
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence. Urinary tract infection (recurrent): antimicrobial prescribing [Internet]. London (UK): National Institute for Health and Care Excellence. (2018) [cited 2018 Oct 31]. Available from: https://www.nice.org.uk/guidance/ng112
   Google Scholar
• Hari P, Hari S, Sinha A, et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double-blind placebo-controlled trial. Pediatr Nephrol. 2015;30(3):479–486.
   PubMed Web of Science ®Google Scholar
• Wang HH, Gbadegesin RA, Foreman JW, et al. Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis. J Urol. 2015;193(3):963–969.
   PubMed Web of Science ®Google Scholar
• Alsubaie SS, Barry MA. Current status of long-term antibiotic prophylaxis for urinary tract infections in children: an antibiotic stewardship challenge. Kidney Res Clin Pract. 2019;38(4):441–454.
   PubMed Web of Science ®Google Scholar
• Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA. 2014;311(8):844–854.
   PubMed Web of Science ®Google Scholar
• Owens DK, Davidson KW, Krist AH, et al. Screening for asymptomatic bacteriuria in adults: US preventive services task force recommendation statement. JAMA. 2019;322(12):1188–1194.
   PubMed Web of Science ®Google Scholar
• Khandelwal P, Abraham SN, Apodaca G. Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol. 2009;297(6):F1477–F1501.
   PubMed Web of Science ®Google Scholar
• Eto DS, Jones TA, Sundsbak JL, et al. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 2007;3(7):e100.
   PubMed Web of Science ®Google Scholar
• Nickel JC. Management of urinary tract infections: historical perspective and current strategies: part 1 - before antibiotics. J Urol. 2005;173(1):21–26.
   PubMed Web of Science ®Google Scholar
• Ebani VV, Nardoni S, Bertelloni F, et al. Antimicrobial activity of five essential oils against bacteria and fungi responsible for urinary tract infections. Molecules. 2018;23(7):1668.
   Web of Science ®Google Scholar
• Lagha R, Ben Abdallah F, Al-Sarhan BO, et al. Antibacterial and biofilm inhibitory activity of medicinal plant essential oils against Escherichia coli isolated from UTI patients. Molecules. 2019;24(6):1161.
   Web of Science ®Google Scholar
• Sharifi-Rad J, Mnayer D, Roointan A, et al. Antibacterial activities of essential oils from Iranian medicinal plants on extended-spectrum β-lactamase-producing Escherichia coli. Cell Mol Biol. 2016;62(9):75–82.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim YG, Lee J. Carvacrol-rich oregano oil and thymol-rich thyme red oil inhibit biofilm formation and the virulence of uropathogenic Escherichia coli. J Appl Microbiol. 2017;123(6):1420–1428.
   PubMed Web of Science ®Google Scholar
• Sienkiewicz M, Łysakowska M, Pastuszka M, et al. The potential of use basil and rosemary essential oils as effective antibacterial agents. Molecules. 2013;18(8):9334–9351.
   PubMed Web of Science ®Google Scholar
• Malik T, Singh P, Pant S, et al. Potentiation of antimicrobial activity of ciprofloxacin by Pelargonium graveolens essential oil against selected uropathogens. Phytother Res. 2011;25(8):1225–1228.
   PubMed Web of Science ®Google Scholar
• Pereira RS, Sumita TC, Furlan MR, et al. Antibacterial activity of essential oils on microorganisms isolated from urinary tract infection. Rev Saude Publica. 2004;38(2):326–328.
   PubMed Web of Science ®Google Scholar
• Zapién-Chavarría KA, Plascencia-Terrazas A, Venegas-Ortega MG, et al. Susceptibility of Multidrug-resistant and biofilm-forming uropathogens to Mexican oregano essential oil. Antibiotics. 2019;8(4):186.
   Google Scholar
• Marcon J, Schubert S, Stief CG, et al. In vitro efficacy of phytotherapeutics suggested for prevention and therapy of urinary tract infections. Infection. 2019;47(6):937–944.
   PubMed Web of Science ®Google Scholar
• Vogel NW, Taschetto AP, Dall’agnol R, et al. Assessment of the antimicrobial effect of three plants used for therapy of community-acquired urinary tract infection in Rio Grande do Sul (Brazil). J Ethnopharmacol. 2011;137(3):1334–1336.
   PubMed Web of Science ®Google Scholar
• Okragla E, Chraniuk M, Wolska L. Microtox test as a tool to assess antimicrobial properties of herbal infusions used in urinary tract infections. Acta Pol Pharm. 2017;74(3):895–901.
   PubMed Web of Science ®Google Scholar
• Ukah UV, Glass M, Avery B, et al. Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract infections. Epidemiol Infect. 2018;146(1):46–57.
   PubMed Web of Science ®Google Scholar
• Liu SW, Guo J, Wu WK, et al. Treatment of uncomplicated recurrent urinary tract infection with Chinese medicine formula: a randomized controlled trial. Chin J Integr Med. 2019;25(1):16–22.
   PubMed Web of Science ®Google Scholar
• Tong YQ, Sun M, Chi Y. Prophylactic herbal therapy prevents experimental ascending urinary tract infection in mice. Chin J Integr Med. 2016;22(10):774–777.
   PubMed Web of Science ®Google Scholar
• Lüthje P, Brauner A. Novel strategies in the prevention and treatment of urinary tract infections. Pathogens. 2016;5(1):13.
   Web of Science ®Google Scholar
• Dumitrascu A, Senn L, Rothuizen L, et al. Acute respiratory and urinary tract infections in medical practice: a selection of complementary medicines. Rev Med Suisse. 2019;15(648):875–881.
   PubMedGoogle Scholar
• Kazemian H, Ghafourian S, Heidari H, et al. Antibacterial, anti-swarming and anti-biofilm formation activities of Chamaemelum nobile against Pseudomonas aeruginosa. Rev Soc Bras Med Trop. 2015;48(4):432–436.
   PubMed Web of Science ®Google Scholar
• Tong Y, Jia S, Han B. Chinese herb-resistant clinical isolates of Escherichia coli. J Altern Complement Med. 2013;19(4):387–388.
   PubMed Web of Science ®Google Scholar
• Tong Y, Leng Y, Bai J. Chinese herbal medicine: a safe alternative therapy for urinary tract infection in patients with renal insufficiency. Afr J Tradit Complement Altern Med. 2011;9(2):266–270.
   PubMedGoogle Scholar
• Tong Y, Jing Y, Zhao D, et al. Fluoroquinolone-resistant uncomplicated urinary tract infections, Chinese herbal medicine may provide help. Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):108–114.
   PubMedGoogle Scholar
• Tong Y, Jia Q, Sun Y. A renal tuberculosis case: could Chinese medicine play a role? J Altern Complement Med. 2009;15(8):939–941.
   PubMed Web of Science ®Google Scholar
• Mickymaray S, Al AMS. In vitro antioxidant and bactericidal efficacy of 15 common spices: novel therapeutics for urinary tract infections? Medicina (Lithuania). 2019;55(6):289.
   Web of Science ®Google Scholar
• Petrolini FV, Lucarini R, de Souza MG, et al. Evaluation of the antibacterial potential of Petroselinum crispum and Rosmarinus officinalis against bacteria that cause urinary tract infections. Braz J Microbiol. 2013;44(3):829–834.
   PubMed Web of Science ®Google Scholar
• Harjai K, Kumar R, Singh S. Garlic blocks quorum sensing and attenuates the virulence of Pseudomonas aeruginosa. FEMS Immunol Med Microbiol. 2010;58(2):161–168.
   PubMedGoogle Scholar
• Sohn DW, Han CH, Jung YS, et al. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model. Int J Antimicrob Agents. 2009;34(3):215–219.
   PubMed Web of Science ®Google Scholar
• Vadekeetil A, Chhibber S, Harjai K. Efficacy of intravesical targeting of novel quorum sensing inhibitor nanoparticles against Pseudomonas aeruginosa biofilm-associated murine pyelonephritis. J Drug Target. 2019 Nov;27(9):995–1003.
   PubMed Web of Science ®Google Scholar
• Mantzorou M, Giaginis C. Cranberry consumption against urinary tract infections: clinical state of- the-art and future perspectives. Curr Pharm Biotechnol. 2018;19(13):1049–1063.
   PubMed Web of Science ®Google Scholar
• Vadekeetil A, Alexandar V, Chhibber S, et al. Adjuvant effect of cranberry proanthocyanidin active fraction on antivirulent property of ciprofloxacin against Pseudomonas aeruginosa. Microb Pathog. 2016;90:98–103.
   PubMed Web of Science ®Google Scholar
• Alfaro-Viquez E, Esquivel-Alvarado D, Madrigal-Carballo S, et al. Cranberry proanthocyanidin-chitosan hybrid nanoparticles as a potential inhibitor of extra-intestinal pathogenic Escherichia coli invasion of gut epithelial cells. Int J Biol Macromol. 2018;111:415–420.
   PubMed Web of Science ®Google Scholar
• Alfaro-Viquez E, Esquivel-Alvarado D, Madrigal-Carballo S, et al. Proanthocyanidin-chitosan composite nanoparticles prevent bacterial invasion and colonization of gut epithelial cells by extra-intestinal pathogenic Escherichia coli. Int J Biol Macromol. 2019;135:630–636.
   PubMed Web of Science ®Google Scholar
• Ayyash M, Shehabi AA, Mahmoud NN, et al. Antibiofilm properties of triclosan with EDTA or cranberry as Foley Catheter lock solutions. J Appl Microbiol. 2019;127(6):1876–1888.
   PubMed Web of Science ®Google Scholar
• Lau I, Albrecht U, Kirschner-Hermanns R. Phytotherapy in catheter-associated urinary tract infection: observational study recording the efficacy and safety of a fixed herbal combination containing Tropaeoli majoris herba and Armoraciae rusticanae radix. Urologe A. 2018;57(12):1472–1480.
   PubMedGoogle Scholar
• Nausch B, Pace S, Pein H, et al. The standardized herbal combination BNO 2103 contained in Canephron® N alleviates inflammatory pain in experimental cystitis and prostatitis. Phytomedicine. 2019;60:152987.
   PubMed Web of Science ®Google Scholar
• Genovese C, Davinelli S, Mangano K, et al. Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. J Chemother. 2018;30(2):107–114.
   PubMed Web of Science ®Google Scholar